Elicera Therapeutics (ELIC)

Last close As at 12/03/2025

SEK2.45

0.15 (6.52%)

Market capitalisation

SEK86m

Elicera Therapeutics is a Sweden-based clinical-stage cell and gene therapy company focused on developing next generation immuno-oncology treatments based on iTANK-armed oncolytic viruses and CAR-T cells.

Latest Insights

Sector

Healthcare

Equity Analyst

Jyoti Prakash

Jyoti Prakash, CFA

Director, healthcare

Key Management

  • Ingvar Karlsson

    CFO

  • Jamal El-Mosleh

    CEO and co-founder

Thematics

thematic

Healthcare

Healthcare-focused trusts: A sector on the mend

thematic

Healthcare

Deutsches Eigenkapitalforum (EKF) 2023 healthcare

volition01

thematic

Healthcare

VolitionRx – Decoding the DNA of cancer 

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free